131 related articles for article (PubMed ID: 8724534)
21. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh.
al-Katib A; Mohammad RM; Khan K; Dan ME; Pettit GR; Sensenbrenner LL
J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):33-42. PubMed ID: 8399068
[TBL] [Abstract][Full Text] [Related]
22. Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.
Hu ZB; Gignac SM; Uphoff CC; Quentmeier H; Steube KG; Drexler HG
Leuk Lymphoma; 1993 May; 10(1-2):135-42. PubMed ID: 8374521
[TBL] [Abstract][Full Text] [Related]
23. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
[TBL] [Abstract][Full Text] [Related]
24. Two protein kinase C activators, bryostatin-1 and phorbol-12-myristate-13-acetate, have different effects on haemopoietic cell proliferation and differentiation.
Ng SB; Guy GR
Cell Signal; 1992 Jul; 4(4):405-16. PubMed ID: 1419483
[TBL] [Abstract][Full Text] [Related]
25. In-vitro induction of some features of hairy cell leukemia in chronic lymphocytic leukemia and immunocytoma cells.
Ziegler-Heitbrock HW; Dörken B; Munker R; Riethmüller G; Thierfelder S; Thiel E
Blut; 1985 Jan; 50(1):29-31. PubMed ID: 3967098
[TBL] [Abstract][Full Text] [Related]
26. Effects of bryostatins and retinoic acid on phorbol ester- and diacylglycerol-induced squamous differentiation in human tracheobronchial epithelial cells.
Jetten AM; George MA; Pettit GR; Rearick JI
Cancer Res; 1989 Jul; 49(14):3990-5. PubMed ID: 2567623
[TBL] [Abstract][Full Text] [Related]
27. Expression of proto-oncogene c-jun during differentiation of B-chronic lymphocytic leukemia.
Gignac SM; Buschie M; Pettit GR; Hoffbrand AV; Drexler HG
Leukemia; 1990 Jun; 4(6):441-4. PubMed ID: 2113601
[TBL] [Abstract][Full Text] [Related]
28. Effects of lymph node stromal cells on the differentiation of a cell line established from an atypical prolymphocytic leukemia with phenotypes of both chronic lymphocytic and hairy cell leukemias.
Takeuchi H; Amano Y; Katayama I
Leuk Lymphoma; 1994; 14 Suppl 1():49-56. PubMed ID: 7820053
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders.
Trentin L; Cerutti A; Zambello R; Sancretta R; Tassinari C; Facco M; Adami F; Rodeghiero F; Agostini C; Semenzato G
Blood; 1996 Apr; 87(8):3327-35. PubMed ID: 8605349
[TBL] [Abstract][Full Text] [Related]
30. Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias.
Takeuchi H; Katayama I
Leuk Lymphoma; 1993 Jun; 10(3):209-16. PubMed ID: 8220119
[TBL] [Abstract][Full Text] [Related]
31. Similarities between the sensitivity to 2-chlorodeoxyadenosine of lymphocytes from CLL patients and bryostatin 1-treated WSU-CLL cells: an infrared spectroscopic study.
Liu KZ; Schultz CP; Mohammad RM; Al-Katib AM; Johnston JB; Mantsch HH
Cancer Lett; 1998 May; 127(1-2):185-93. PubMed ID: 9619876
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Oct; 7(10):1576-84. PubMed ID: 8105156
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic modulation of chronic lymphocytic, prolymphocytic, and lymphoplasmacytic leukemia cells by TPA: induction of TRAP isoenzyme 5 and HD6 (CD22) antigen and enhancement of IgM messenger RNA.
Thiel E; Pachmann K; Dörken B; Gaedicke G; Ziegler-Heitbrock HW
Blood Cells; 1987; 12(2):365-83. PubMed ID: 3476168
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
Meinhardt G; Roth J; Totok G
Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
[TBL] [Abstract][Full Text] [Related]
35. Action of phorbol esters, bryostatins, and retinoic acid on cholesterol sulfate synthesis: relation to the multistep process of differentiation in human epidermal keratinocytes.
Jetten AM; George MA; Pettit GR; Herald CL; Rearick JI
J Invest Dermatol; 1989 Jul; 93(1):108-15. PubMed ID: 2473132
[TBL] [Abstract][Full Text] [Related]
36. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
37. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines.
Mohammad RM; al-Katib A; Pettit GR; Sensenbrenner LL
Leuk Res; 1993 Jan; 17(1):1-8. PubMed ID: 8429674
[TBL] [Abstract][Full Text] [Related]
39. Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro.
Ning ZQ; Hirose T; Deed R; Newton J; Murphy JJ; Norton JD
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):59-65. PubMed ID: 8870649
[TBL] [Abstract][Full Text] [Related]
40. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
